Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.009 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.009 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |